Global Intravitreal Injectable Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

1 Report Overview
1.1 Study Scope
1.2 Market by Drug
1.2.1 Global Market Size Growth by Drug: 2020 VS 2024 VS 2031
1.2.2 Anti-VEGF
1.2.3 Steroids
1.2.4 Others
1.3 Market by Disease
1.3.1 Global Market Share by Disease: 2020 VS 2024 VS 2031
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intravitreal Injectable Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Intravitreal Injectable Revenue Market Share by Region (2020-2025)
2.4 Global Intravitreal Injectable Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Intravitreal Injectable Market Size and Prospective (2020-2031)
2.5.2 Europe Intravitreal Injectable Market Size and Prospective (2020-2031)
2.5.3 China Intravitreal Injectable Market Size and Prospective (2020-2031)
3 Breakdown Data by Drug
3.1 Global Intravitreal Injectable Historic Market Size by Drug (2020-2025)
3.2 Global Intravitreal Injectable Forecasted Market Size by Drug (2026-2031)
3.3 Different Types Intravitreal Injectable Representative Players
4 Breakdown Data by Disease
4.1 Global Intravitreal Injectable Historic Market Size by Disease (2020-2025)
4.2 Global Intravitreal Injectable Forecasted Market Size by Disease (2026-2031)
4.3 New Sources of Growth in Intravitreal Injectable Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Intravitreal Injectable Players by Revenue (2020-2025)
5.1.2 Global Intravitreal Injectable Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Intravitreal Injectable Revenue
5.4 Global Intravitreal Injectable Market Concentration Analysis
5.4.1 Global Intravitreal Injectable Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Intravitreal Injectable Revenue in 2024
5.5 Global Key Players of Intravitreal Injectable Head office and Area Served
5.6 Global Key Players of Intravitreal Injectable, Product and Application
5.7 Global Key Players of Intravitreal Injectable, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Intravitreal Injectable Revenue by Company (2020-2025)
6.1.2 North America Market Size by Drug
6.1.2.1 North America Intravitreal Injectable Market Size by Drug (2020-2025)
6.1.2.2 North America Intravitreal Injectable Market Share by Drug (2020-2025)
6.1.3 North America Market Size by Disease
6.1.3.1 North America Intravitreal Injectable Market Size by Disease (2020-2025)
6.1.3.2 North America Intravitreal Injectable Market Share by Disease (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Intravitreal Injectable Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Drug
6.2.2.1 Europe Intravitreal Injectable Market Size by Drug (2020-2025)
6.2.2.2 Europe Intravitreal Injectable Market Share by Drug (2020-2025)
6.2.3 Europe Market Size by Disease
6.2.3.1 Europe Intravitreal Injectable Market Size by Disease (2020-2025)
6.2.3.2 Europe Intravitreal Injectable Market Share by Disease (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Intravitreal Injectable Revenue by Company (2020-2025)
6.3.2 China Market Size by Drug
6.3.2.1 China Intravitreal Injectable Market Size by Drug (2020-2025)
6.3.2.2 China Intravitreal Injectable Market Share by Drug (2020-2025)
6.3.3 China Market Size by Disease
6.3.3.1 China Intravitreal Injectable Market Size by Disease (2020-2025)
6.3.3.2 China Intravitreal Injectable Market Share by Disease (2020-2025)
6.3.4 China Market Trend and Opportunities
7 Key Players Profiles
7.1 Regeneron Pharmaceuticals (Eylea)
7.1.1 Regeneron Pharmaceuticals (Eylea) Company Details
7.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
7.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Introduction
7.1.4 Regeneron Pharmaceuticals (Eylea) Revenue in Intravitreal Injectable Business (2020-2025)
7.1.5 Regeneron Pharmaceuticals (Eylea) Recent Development
7.2 Allergan
7.2.1 Allergan Company Details
7.2.2 Allergan Business Overview
7.2.3 Allergan Intravitreal Injectable Introduction
7.2.4 Allergan Revenue in Intravitreal Injectable Business (2020-2025)
7.2.5 Allergan Recent Development
7.3 EyePoint Pharmaceuticals
7.3.1 EyePoint Pharmaceuticals Company Details
7.3.2 EyePoint Pharmaceuticals Business Overview
7.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Introduction
7.3.4 EyePoint Pharmaceuticals Revenue in Intravitreal Injectable Business (2020-2025)
7.3.5 EyePoint Pharmaceuticals Recent Development
7.4 Genentech
7.4.1 Genentech Company Details
7.4.2 Genentech Business Overview
7.4.3 Genentech Intravitreal Injectable Introduction
7.4.4 Genentech Revenue in Intravitreal Injectable Business (2020-2025)
7.4.5 Genentech Recent Development
7.5 Kanghong Pharmaceutical
7.5.1 Kanghong Pharmaceutical Company Details
7.5.2 Kanghong Pharmaceutical Business Overview
7.5.3 Kanghong Pharmaceutical Intravitreal Injectable Introduction
7.5.4 Kanghong Pharmaceutical Revenue in Intravitreal Injectable Business (2020-2025)
7.5.5 Kanghong Pharmaceutical Recent Development
7.6 Astellas Pharma
7.6.1 Astellas Pharma Company Details
7.6.2 Astellas Pharma Business Overview
7.6.3 Astellas Pharma Intravitreal Injectable Introduction
7.6.4 Astellas Pharma Revenue in Intravitreal Injectable Business (2020-2025)
7.6.5 Astellas Pharma Recent Development
7.7 Clearside Biomedical
7.7.1 Clearside Biomedical Company Details
7.7.2 Clearside Biomedical Business Overview
7.7.3 Clearside Biomedical Intravitreal Injectable Introduction
7.7.4 Clearside Biomedical Revenue in Intravitreal Injectable Business (2020-2025)
7.7.5 Clearside Biomedical Recent Development
7.8 Bayer
7.8.1 Bayer Company Details
7.8.2 Bayer Business Overview
7.8.3 Bayer Intravitreal Injectable Introduction
7.8.4 Bayer Revenue in Intravitreal Injectable Business (2020-2025)
7.8.5 Bayer Recent Development
8 Intravitreal Injectable Market Dynamics
8.1 Intravitreal Injectable Industry Trends
8.2 Intravitreal Injectable Market Drivers
8.3 Intravitreal Injectable Market Challenges
8.4 Intravitreal Injectable Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Global Intravitreal Injectable Market Size Growth Rate by Drug (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Intravitreal Injectable Market Size Growth by Disease (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Intravitreal Injectable Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Intravitreal Injectable Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Intravitreal Injectable Revenue Share by Region (2020-2025)
Table 6. Global Intravitreal Injectable Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Intravitreal Injectable Revenue Share Forecast by Region (2026-2031)
Table 8. Global Intravitreal Injectable Market Size by Drug (2020-2025) & (US$ Million)
Table 9. Global Intravitreal Injectable Revenue Market Share by Drug (2020-2025)
Table 10. Global Intravitreal Injectable Forecasted Market Size by Drug (2026-2031) & (US$ Million)
Table 11. Global Intravitreal Injectable Revenue Market Share by Drug (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Intravitreal Injectable Market Size by Disease (2020-2025) & (US$ Million)
Table 14. Global Intravitreal Injectable Revenue Market Share by Disease (2020-2025)
Table 15. Global Intravitreal Injectable Forecasted Market Size by Disease (2026-2031) & (US$ Million)
Table 16. Global Intravitreal Injectable Revenue Market Share by Disease (2026-2031)
Table 17. New Sources of Growth in Intravitreal Injectable Application
Table 18. Global Intravitreal Injectable Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Intravitreal Injectable Market Share by Players (2020-2025)
Table 20. Global Top Intravitreal Injectable Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2024)
Table 21. Ranking of Global Top Intravitreal Injectable Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Intravitreal Injectable Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Intravitreal Injectable, Headquarters and Area Served
Table 24. Global Key Players of Intravitreal Injectable, Product and Application
Table 25. Global Key Players of Intravitreal Injectable, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Intravitreal Injectable Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Intravitreal Injectable Revenue Market Share by Company (2020-2025)
Table 29. North America Intravitreal Injectable Market Size by Drug (2020-2025) & (US$ Million)
Table 30. North America Intravitreal Injectable Market Size by Disease (2020-2025) & (US$ Million)
Table 31. Europe Intravitreal Injectable Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Intravitreal Injectable Revenue Market Share by Company (2020-2025)
Table 33. Europe Intravitreal Injectable Market Size by Drug (2020-2025) & (US$ Million)
Table 34. Europe Intravitreal Injectable Market Size by Disease (2020-2025) & (US$ Million)
Table 35. China Intravitreal Injectable Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Intravitreal Injectable Revenue Market Share by Company (2020-2025)
Table 37. China Intravitreal Injectable Market Size by Drug (2020-2025) & (US$ Million)
Table 38. China Intravitreal Injectable Market Size by Disease (2020-2025) & (US$ Million)
Table 39. Regeneron Pharmaceuticals (Eylea) Company Details
Table 40. Regeneron Pharmaceuticals (Eylea) Business Overview
Table 41. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product
Table 42. Regeneron Pharmaceuticals (Eylea) Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)
Table 43. Regeneron Pharmaceuticals (Eylea) Recent Development
Table 44. Allergan Company Details
Table 45. Allergan Business Overview
Table 46. Allergan Intravitreal Injectable Product
Table 47. Allergan Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)
Table 48. Allergan Recent Development
Table 49. EyePoint Pharmaceuticals Company Details
Table 50. EyePoint Pharmaceuticals Business Overview
Table 51. EyePoint Pharmaceuticals Intravitreal Injectable Product
Table 52. EyePoint Pharmaceuticals Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)
Table 53. EyePoint Pharmaceuticals Recent Development
Table 54. Genentech Company Details
Table 55. Genentech Business Overview
Table 56. Genentech Intravitreal Injectable Product
Table 57. Genentech Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)
Table 58. Genentech Recent Development
Table 59. Kanghong Pharmaceutical Company Details
Table 60. Kanghong Pharmaceutical Business Overview
Table 61. Kanghong Pharmaceutical Intravitreal Injectable Product
Table 62. Kanghong Pharmaceutical Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)
Table 63. Kanghong Pharmaceutical Recent Development
Table 64. Astellas Pharma Company Details
Table 65. Astellas Pharma Business Overview
Table 66. Astellas Pharma Intravitreal Injectable Product
Table 67. Astellas Pharma Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)
Table 68. Astellas Pharma Recent Development
Table 69. Clearside Biomedical Company Details
Table 70. Clearside Biomedical Business Overview
Table 71. Clearside Biomedical Intravitreal Injectable Product
Table 72. Clearside Biomedical Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)
Table 73. Clearside Biomedical Recent Development
Table 74. Bayer Company Details
Table 75. Bayer Business Overview
Table 76. Bayer Intravitreal Injectable Product
Table 77. Bayer Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)
Table 78. Bayer Recent Development
Table 79. Intravitreal Injectable Market Trends
Table 80. Intravitreal Injectable Market Drivers
Table 81. Intravitreal Injectable Market Challenges
Table 82. Intravitreal Injectable Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources


List of Figures
Figure 1. Intravitreal Injectable Product Picture
Figure 2. Global Intravitreal Injectable Market Share by Drug: 2024 VS 2031
Figure 3. Anti-VEGF Features
Figure 4. Steroids Features
Figure 5. Others Features
Figure 6. Global Intravitreal Injectable Market Share by Disease: 2024 VS 2031
Figure 7. Macular Degeneration
Figure 8. Macular Edema
Figure 9. Uveitis
Figure 10. Retinal Vein Occlusion
Figure 11. Others
Figure 12. Intravitreal Injectable Report Years Considered
Figure 13. Global Intravitreal Injectable Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Intravitreal Injectable Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Intravitreal Injectable Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Intravitreal Injectable Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Intravitreal Injectable Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Intravitreal Injectable Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Intravitreal Injectable Market Share by Players in 2024
Figure 20. Global Top Intravitreal Injectable Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Intravitreal Injectable Revenue in 2024
Figure 22. North America Intravitreal Injectable Market Share by Drug (2020-2025)
Figure 23. North America Intravitreal Injectable Market Share by Disease (2020-2025)
Figure 24. Europe Intravitreal Injectable Market Share by Drug (2020-2025)
Figure 25. Europe Intravitreal Injectable Market Share by Disease (2020-2025)
Figure 26. China Intravitreal Injectable Market Share by Drug (2020-2025)
Figure 27. China Intravitreal Injectable Market Share by Disease (2020-2025)
Figure 28. Regeneron Pharmaceuticals (Eylea) Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)
Figure 29. Allergan Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)
Figure 30. EyePoint Pharmaceuticals Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)
Figure 31. Genentech Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)
Figure 32. Kanghong Pharmaceutical Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)
Figure 33. Astellas Pharma Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)
Figure 34. Clearside Biomedical Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)
Figure 35. Bayer Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit